Hyundai Pharmaceutical Co. Ltd. | Balance Sheet
Fiscal year is December-November. All values KRW Millions.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
14,630
13,790
10,409
8,622
8,234
7,362
Total Accounts Receivable
44,763
46,003
47,280
54,267
59,598
62,786
Inventories
20,971
19,359
18,556
17,118
17,206
17,732
Other Current Assets
113
118
124
96
1,892
1,498
Total Current Assets
80,477
79,269
76,369
80,103
86,930
89,378
Net Property, Plant & Equipment
33,346
32,705
32,454
32,655
33,000
32,887
Total Investments and Advances
25,986
33,442
35,882
30,574
29,474
30,743
Intangible Assets
1,829
1,794
1,749
3,204
3,796
4,279
Other Assets
1,765
84
84
1,692
1,417
1,180
Total Assets
145,742
150,166
148,974
151,566
157,779
162,803
ST Debt & Current Portion LT Debt
20,750
18,764
21,000
26,936
29,453
Accounts Payable
6,855
8,488
7,274
9,907
11,021
Income Tax Payable
59
217
764
125
421
Other Current Liabilities
8,980
8,469
8,449
7,557
8,123
Total Current Liabilities
36,644
35,938
37,488
44,524
49,017
Provision for Risks & Charges
3,381
3,584
2,298
4,709
6,239
Deferred Taxes
1,932
2,533
1,490
295
452
Other Liabilities
-
-
-
-
-
Total Liabilities
44,296
44,927
43,712
52,866
58,871
Common Equity (Total)
100,705
104,687
104,432
97,763
98,098
Total Shareholders' Equity
100,705
104,687
104,432
97,763
98,098
Total Equity
101,212
104,687
104,432
97,763
98,098
Liabilities & Shareholders' Equity
145,742
150,166
148,974
151,566
157,779
Accumulated Minority Interest
507
-
-
-
-
Non-Equity Reserves
234
553
830
937
810
About Hyundai Pharmaceutical Co.
View Profile
